Electronic Trigger for Microhematuria
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- NYU Langone Health
- Enrollment
- 2,000
- Locations
- 1
- Primary Endpoint
- Evaluation rate
Study Overview
Brief Summary
The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders.
Detailed Description
The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders. The message will notify users that a patient has clinically significant microscopic hematuria and is at high risk for underlying malignancy and will include the official recommendations (imaging with a CT urogram, urology evaluation with cystoscopy).
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Screening
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 35 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •35 years of age or older
- •3+ RBC on Urinalysis
- •Urinalysis sent during an outpatient encounter
- •any of the following: 60 years of age or older; RBC > 25; current or prior tobacco use; Gross Hematuria
Exclusion Criteria
- •Under 35 years of age
- •Cystoscopy within 1 year prior to Urinalysis
- •Nitrite positive AND Leukocyte Esterase positive
- •Nitrite positive AND >100 WBC
- •Leukocyte Esterase positive AND >100 WBC
- •Know GU cancer diagnosis
- •Urinalysis ordered by urology provider
Outcomes
Primary Outcomes
Evaluation rate
Time Frame: 180 days of alert
Urology evaluation with cystoscopy and appropriate imaging
Secondary Outcomes
No secondary outcomes reported
